Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R McCrae

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
Blood Advances|January 20, 2022
Eculizumab for refractory thrombosis in antiphospholipid syndromeHabiba Hussain, Michael D Tarantino, Shruti Chaturvedi, et al.
Blood|August 20, 2013
Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathwayVenkaiah Betapudi, George Lominadze, Linda Hsi, et al.
Advances in Experimental Medicine and Biology|February 13, 2009
Human tropomyosin isoforms in the regulation of cytoskeleton functionsJim Jung-Ching Lin, Robbin D Eppinga, Kerri S Warren, et al.
Current Cancer Drug Targets|November 25, 2005
Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5Keith R McCrae, Fernando Doñate, Sergei Merkulov, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 19, 2011
Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticlesVicky Cheng, Sangeeta R Kashyap, Philip R Schauer, et al.
Journal of Vascular Surgery|October 9, 2002
Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitorHans A Brings, John K Waas, Keith R McCrae, et al.
Frontiers in Medicine|December 12, 2019
Editorial: Proceedings of KININ2018CLE, Cleveland, Ohio, June 18-20, 2018: A Compendium of the PresentationsAlvin H Schmaier, Marvin T Nieman, Keith R McCrae, et al.
Thrombosis and Haemostasis|December 31, 2019
Outcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HITDaniel S Carlson, John R Bartholomew, Marcelo P Gomes, et al.
Journal for Immunotherapy of Cancer|January 13, 2021
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survivalTamara A Sussman, Hong Li, Brian Hobbs, et al.
Blood|November 23, 2011
A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodiesKristi L Allen, Fabio V Fonseca, Venkaiah Betapudi, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Blood Advances|January 20, 2022
Eculizumab for refractory thrombosis in antiphospholipid syndromeHabiba Hussain, Michael D Tarantino, Shruti Chaturvedi, et al.
Blood|August 20, 2013
Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathwayVenkaiah Betapudi, George Lominadze, Linda Hsi, et al.
Advances in Experimental Medicine and Biology|February 13, 2009
Human tropomyosin isoforms in the regulation of cytoskeleton functionsJim Jung-Ching Lin, Robbin D Eppinga, Kerri S Warren, et al.
Current Cancer Drug Targets|November 25, 2005
Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5Keith R McCrae, Fernando Doñate, Sergei Merkulov, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 19, 2011
Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticlesVicky Cheng, Sangeeta R Kashyap, Philip R Schauer, et al.
Journal of Vascular Surgery|October 9, 2002
Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitorHans A Brings, John K Waas, Keith R McCrae, et al.
Frontiers in Medicine|December 12, 2019
Editorial: Proceedings of KININ2018CLE, Cleveland, Ohio, June 18-20, 2018: A Compendium of the PresentationsAlvin H Schmaier, Marvin T Nieman, Keith R McCrae, et al.
Thrombosis and Haemostasis|December 31, 2019
Outcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HITDaniel S Carlson, John R Bartholomew, Marcelo P Gomes, et al.
Journal for Immunotherapy of Cancer|January 13, 2021
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survivalTamara A Sussman, Hong Li, Brian Hobbs, et al.
Blood|November 23, 2011
A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodiesKristi L Allen, Fabio V Fonseca, Venkaiah Betapudi, et al.
Pageof 16